Opinion|Videos|November 8, 2024
Personalizing Treatments and Patient Education
Key Takeaways
- Personalizing treatment regimens involves adjusting dosing schedules and administration routes to improve adherence and quality of life.
- Evaluating patient-specific factors, such as lifestyle and preferences, is crucial in developing personalized treatment plans.
Panelists discuss how treatment regimens for multiple myeloma patients can be personalized to improve adherence and quality of life by considering factors such as dosing schedules and routes of administration while emphasizing the role of pharmacists in providing resources and support to keep patients informed, engaged, and compliant with their individualized treatment plans.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can a patient's treatment regimen be personalized to improve adherence and quality of life (eg, dosing schedule, route of administration), and how are those factors weighed or evaluated when developing treatment plans?
- (Dr Adams) What resources or support can pharmacists offer to keep patients informed, engaged, and compliant with their treatment plans?
Advertisement
Related to this article
Pharmacists make a difference in patients’ lives through MTM services.
Peptide cancer vaccines target neoantigens to boost T cells, with promising melanoma and pancreatic trials hinting at a new era in immunotherapy.
AI tools in pharmacy education risk eroding critical thinking, lab competency, and patient safety if used as substitutes for foundational learning.
The Main Street Pharmacy Access Act would let Medicare pay pharmacists for care they can already legally provide, if pharmacies have the time.
Ali A. Habib, MD, discusses how NIMBLE’s hospitalization findings complement symptom outcomes for investigational cemdisiran and highlights pharmacists’ role in vaccination tracking and infection-risk counseling.
Rather than requiring a new trial, the FDA extended evidence from carcinoma in situ to high-grade papillary-only disease, a new approach for this setting.
Pharmacists can address patient fears about fentanyl by distinguishing illicit from prescribed opioids and promoting safe, empathetic, evidence-based opioid use.
Nationwide Danish data presented at EASD 2026 link a widening cancer gap in type 2 diabetes largely to obesity-related cancers.
Advertisement
Advertisement
Trending on Pharmacy Times
1
VYD2311 May Offer Vaccine-Hesitant and Immunocompromised Individuals a New COVID-19 Immunization Option
2
National Pharmacy Technician Day: Celebrating the Backbone of Pharmacy
3
Cemdisiran’s Potential to Reduce Hospitalizations in Myasthenia Gravis
4
Pneumonic Plague: What Pharmacists Need to Know About Treatment
5